Charlotte Chance
Family · McAlester, OKNPI 1326407396
Payments from drug & device makers
Across 129 payments — averaging $16.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$227
- Novo Nordisk$188
- AstraZeneca$155
- Smith+Nephew$152
- Sanofi-aventis U.S. LLC$143
- GSK$111
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,064100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 15 | $227 |
| Novo Nordisk | 11 | $188 |
| AstraZeneca(2 entities) | 9 | $155 |
| Smith+Nephew | 13 | $152 |
| Sanofi-aventis U.S. LLC | 11 | $143 |
| GSK | 8 | $111 |
| Sumitomo Pharma America, Inc. | 3 | $84 |
| AbbVie | 4 | $78 |
| Johnson & Johnson | 5 | $65 |
| Amgen | 4 | $65 |
| Pfizer | 4 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Next Science LLC | 3 | $44 |
| Paratek Pharmaceuticals, Inc. | 2 | $41 |
| Novartis | 3 | $40 |
| Organogenesis Inc. | 2 | $39 |
| Daiichi Sankyo Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Bayer | 2 | $38 |
| Seagen Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Sunovion Pharmaceuticals Inc. | 2 | $32 |
| Exact Sciences | 2 | $30 |
| Boehringer Ingelheim | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $28 |
| Seqirus USA Inc | 1 | $26 |
| Amarin Pharma, Inc. | 1 | $24 |
| Merck | 1 | $22 |
| Antares Pharma, Inc. | 1 | $20 |
| Reapplix Inc. | 1 | $20 |
| Sobi, Inc | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Alk-abello, Inc | 1 | $17 |
| Biogen | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $13 |
How this compares
$2,064 in reported general payments places this provider in the 80th percentile of 2,026 family providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 110 | $762 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $549 |
| Azithromycin | 94 | $474 |
| Fluticasone Propionate | 39 | $370 |
| Ciprofloxacin Hcl | 33 | $242 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $219 |
| Clindamycin Hcl | 14 | $172 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $157 |
| Tizanidine Hcl | 22 | $134 |
| Mupirocin | 14 | $108 |
| Cephalexin | 11 | $92 |
| Amoxicillin | 17 | $85 |
Paid to pharmacies, not to this prescriber.
Other family in McAlester
- April WilcoxOklahoma City$245K
- Jeremy MorganOklahoma City$63K
- Samantha BellingerOklahoma City$39K
- Candy WilliamsTulsa$22K
- Lacey HillOklahoma City$20K
- Shelby WrightStillwater$17K
- Brandy ReevesNorman$17K
- Amanda OblanderYukon$17K
- Julia John SamuelOklahoma City$17K
- Jillian OakleafTulsa$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.